Ownership history in Clarius Group, LLC · 20 quarters on record
This page tracks every 13F SEC filing in which Clarius Group, LLC reported a position in VIR BIOTECHNOLOGY INC (VIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 608,200 | -11,112 | -1.8% | 0.21% | $3.7M | $6.03 |
| 2025 Q3 | ADDED | 619,312 | +1,777 | +0.3% | 0.21% | $3.5M | $5.71 |
| 2025 Q2 | ADDED | 617,535 | +560,342 | +979.7% | 0.18% | $3.1M | $5.04 |
| 2025 Q1 | UNCHANGED | 57,193 | — | 0% | 0.02% | $371K | $6.48 |
| 2024 Q4 | UNCHANGED | 57,193 | — | 0% | 0.03% | $420K | $7.34 |
| 2024 Q3 | UNCHANGED | 57,193 | — | 0% | 0.03% | $428K | $7.49 |
| 2024 Q2 | UNCHANGED | 57,193 | — | 0% | 0.04% | $509K | $8.90 |
| 2024 Q1 | ADDED | 57,193 | +7,182 | +14.4% | 0.04% | $579K | $10.13 |
| 2023 Q4 | REDUCED | 50,011 | -7,182 | -12.6% | 0.04% | $503K | $10.06 |
| 2023 Q3 | UNCHANGED | 57,193 | — | 0% | 0.05% | $536K | $9.37 |
As of 2025 Q4 — sorted by position size